泼尼松剂量是否影响初次全髋与全膝关节置换术后假体周围关节感染发生率?
基于2015至2020年全国数据库的匹配队列研究,纳入1,322,043例择期全髋或全膝关节置换患者。其中14,585例(1.1%)术后口服泼尼松,按年龄和性别1:2匹配至29,170例未用药患者。控制混杂因素后,泼尼松与假体周围关节感染(PJI)和脓毒症风险升高相关,但未发现剂量依赖性关系。
要点
- 全膝关节置换后口服泼尼松者PJI风险升高(aOR 2.67,P<.001)。
- 全髋关节置换后口服泼尼松者PJI风险升高(aOR 1.73,P=.001)。
- 未发现泼尼松剂量与感染并发症之间的剂量依赖性关系。
核心结论
- 全关节置换术后接受泼尼松治疗的患者PJI和脓毒症风险升高。
- 未发现泼尼松与感染并发症之间的剂量依赖性关系。
研究设计与样本
- 查询2015至2020年全国数据库,纳入所有择期全髋和全膝关节置换患者。
- 术后口服泼尼松的患者按年龄和性别1:2匹配至未用药患者。
- 共1,322,043例患者接受择期全关节置换(全髋35.9%,全膝64.1%)。
- 14,585例(1.1%)接受泼尼松,匹配至29,170例未用药患者。
- 按泼尼松剂量分组(0至5、6至10、11至20、21至30及>30毫克)行单因素和多因素回归分析,评估90天感染并发症风险。
主要发现
- 控制混杂因素后,全膝关节置换患者中泼尼松与脓毒症风险升高相关(aOR 2.76,P<.001)。
- 全膝关节置换患者中泼尼松与PJI风险升高相关(aOR 2.67,P<.001)。
- 全膝关节置换患者中泼尼松与手术部位感染风险升高相关(aOR 2.56,P=.035)。
- 全髋关节置换患者中泼尼松与脓毒症风险升高相关(aOR 3.21,P<.001)。
- 全髋关节置换患者中泼尼松与PJI风险升高相关(aOR 1.73,P=.001)。
临床怎么用
- 关节置换外科医生应知晓这些风险,并对接受泼尼松治疗的全关节置换患者进行告知。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prednisone use is associated with higher rates of periprosthetic joint infection (PJI) following total joint arthroplasty (TJA). However, the relationship between prednisone dosage and infection risk is ill-defined. Therefore, this study aimed to assess the relationship between prednisone dosage and rates of PJI following TJA. METHODS: A national database was queried for all elective total hip (THA) and total knee arthroplasty (TKA) patients between 2015 and 2020. Patients who received oral prednisone following TJA were matched in a 1:2 ratio based on age and sex to patients who did not. Univariate and multivariate regression analyses were performed to assess the 90-day risk of infectious complications based on prednisone dosage as follows: 0 to 5, 6 to 10, 11 to 20, 21 to 30, and >30 milligrams. Overall, 1,322,043 patients underwent elective TJA (35.9% THA, 64.1% TKA). Of these, 14,585 (1.1%) received prednisone and were matched to 29,170 patients who did not. RESULTS: After controlling for confounders, TKA patients taking prednisone were at increased risk for sepsis (adjusted odds ratio [aOR] 2.76, P < .001), PJI (aOR 2.67, P < .001), and surgical site infection (aOR: 2.56, P = .035). THA patients taking prednisone were at increased risk for sepsis (aOR: 3.21, P < .001) and PJI (aOR: 1.73, P = .001). No dose-dependent relationship between prednisone and infectious complications was identified when TJA was assessed in aggregate. CONCLUSION: Patients receiving prednisone following TJA were at increased risk of PJI and sepsis. A dose-dependent relationship between prednisone and infectious complications was not identified. Arthroplasty surgeons should be aware of these risks and counsel TJA patients who receive prednisone therapy.
引用
- Piple AS, Wang JC, Kebaish KJ, et al. Does Prednisone Dose Affect Rates of Periprosthetic Joint Infection Following Primary Total Hip and Total Knee Arthroplasty? J Arthroplasty. 2022. PMID: 36566997. doi:10.1016/j.arth.2022.12.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。